[Federal Register Volume 66, Number 63 (Monday, April 2, 2001)]
[Notices]
[Page 17562]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-7995]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Circulatory System Devices Panel of the Medical Devices Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Circulatory System Devices Panel of the Medical 
Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 23, 2001, 8 a.m. 
to 5 p.m.
    Location: Holiday Inn, Kennedy Grand Ballroom, 8777 Georgia Ave., 
Silver Spring, MD.
    Contact: Megan Moynahan, Center for Devices and Radiological Health 
(HFZ-450), Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD 20850, 301-443-8517, ext. 171, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12625. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The committee will discuss, make recommendations, and vote 
on a premarket approval application for a peripheral stent used in the 
treatment of stenotic or occluded femoral or popliteal arteries. 
Subsequently, the committee will discuss clinical study design issues 
for peripheral stents used in the treatment of stenotic or occluded 
iliac arteries. Background information and questions for the committee 
will be available to the public on April 20, 2001, on the Internet at 
http://www.fda.gov/cdrh/panelmtg.html.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by April 18, 
2001. Oral presentations from the public will be scheduled between 
approximately 8 a.m. and 8:30 a.m. Near the end of the committee 
deliberations, a 30-minute open public session will be conducted for 
interested persons to address issues specific to the submission before 
the committee. Time allotted for each presentation may be limited. 
Those desiring to make formal oral presentations should notify the 
contact person before April 18, 2001, and submit a brief statement of 
the general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication of 
the approximate time requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 26, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-7995 Filed 3-30-01; 8:45 am]
BILLING CODE 4160-01-S